Clinical Trial

Probiotics and Multi-Drug Resistant Urinary Tract Infection

Study Description

Probiotics and Multi-Drug Resistant Urinary Tract Infection

This pilot study is a single-site randomized, double blinded placebo-controlled in females with recurrent multi-drug resistant (MDR) urinary tract infections(UTI). Our study hypothesizes that a novel probiotic strain improves antibiotic sensitivity patterns in these former MDR UTIs.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Antibiotics

Per Infectious Disease Society guidelines for Antimicrobial treatment of uncomplicated cystitis and pyelonephritis in women

Dietary Supplement - Bifidobacterium infantis

Probiotics

Placebo

Sugar pill manufactured to mimic probiotic tablet

Additional Information

Official Study Title

Probiotic and Effects on Multi-Drug Resistant Urinary Tract Infection

Clinical Trial ID

NCT03644966

ParticipAid ID

dyPoPb